caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821296047

Aman GarsaMD

Hematology-OncologyDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
77.4
Quality
82.9
Cost
48.8
Improvement activities
40.0
Promoting interop.
87.0
Payment adjustment
0.10%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$332
Payment records
17
By payment type
Food and Beverage$332
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Aman Garsa's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Kevin Murray
Diagnostic Radiology · Lawton, OK
33115
Nadim Nimeh
Internal Medicine · Lawton, OK
29174
Carol Dittmann
Pathology · Aurora, CO
2485
REDMAN, RACHEL1895
Robbie Graham
Pathology · Lawton, OK
1544
Jimmy Kerley
Radiation Oncology · Lawton, OK
12280
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
286
Unique beneficiaries
—
Total services
330
Distinct HCPCS
8
Medicare payment
$9K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — above median (cohort median 2,625).